(Q48792547)

15 February 2018

title

Development of rolipram-sensitive, cyclic AMP phosphodiesterase (PDE4) in rat primary neuronal cultures (English)

1 reference

15 February 2018

author

Miles D. Houslay

3

1 reference

15 February 2018

author name string

Ye Y

1

1 reference

15 February 2018

Jackson K

2

1 reference

15 February 2018

Chandler LJ

4

1 reference

15 February 2018

O'Donnell JM

5

1 reference

15 February 2018

publication date

1 September 2001

1 reference

15 February 2018

number of pages

7

1 reference

Developmental Brain Research

inferred from page(s)

published in

1 reference

15 February 2018

volume

130

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

page(s)

115-121

1 reference

15 February 2018

Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Therapeutic potential of phosphodiesterase-4 and -3 inhibitors in Th1-mediated autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Alternative splicing of cAMP-specific phosphodiesterase mRNA transcripts. Characterization of a novel tissue-specific isoform, RNPDE4A8.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Chronic ethanol upregulates NMDA and AMPA, but not kainate receptor subunit proteins in rat primary cortical cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

N-methyl D-aspartate receptor-mediated bidirectional control of extracellular signal-regulated kinase activity in cortical neuronal cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Regulation by Follicle-Stimulating Hormone and Dibutyryl Adenosine 3′,5′-Monophosphate of a Phosphodiesterase Isoenzyme of the Sertoli Cell*

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Synapsin I (Protein I), a nerve terminal-specific phosphoprotein. II. Its specific association with synaptic vesicles demonstrated by immunocytochemistry in agarose-embedded synaptosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Cyclic AMP signalling and cellular proliferation: regulation of CREB and CREM.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

A review on neurosecretory granules: their contents and mechanisms of release

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Noradrenergic lesions differentially alter the expression of two subtypes of low Km cAMP-sensitive phosphodiesterase type 4 (PDE4A and PDE4B) in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Surgically Induced Cryptorchidism-Related Degenerative Changes in Spermatogonia Are Associated with Loss of Cyclic Adenosine Monophosphate-Dependent Phosphodiesterases Type 4 in Abdominal Testes of Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Suppression of synapsin II inhibits the formation and maintenance of synapses in hippocampal culture

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Cyclic nucleotide phosphodiesterases: relating structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Emetic, central nervous system, and pulmonary activities of rolipram in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Ameliorating effects of rolipram on experimentally induced impairments of learning and memory in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Behavioral effects of family-selective inhibitors of cyclic nucleotide phosphodiesterases.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

PDE isoenzymes as targets for anti-asthma drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Measurement of protein using bicinchoninic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Diminished noradrenergic stimulation reduces the activity of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase in rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Noradrenergic activity differentially regulates the expression of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase (PDE4) in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Effects of repeated antidepressant treatment of type 4A phosphodiesterase (PDE4A) in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Ontogeny of rolipram-sensitive, low-K(m), cyclic AMP-specific phosphodiesterase in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Effects of noradrenergic lesions on the development of rolipram-sensitive, low-K(m), cyclic AMP specific phosphodiesterase in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2801%2900219-X

7 January 2021

10.1016/S0165-3806(01)00219-X

Identifiers

DOI

1 reference

15 February 2018

release_txuble6465cbfck6hkyxeblgq4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/txuble6465cbfck6hkyxeblgq4

24 November 2022

mapped directly with Wikidata item

1 reference

15 February 2018